
CollPlant Biotechnologies Ltd. CLGN
€ 0.31
-19.32%
Geschäftsbericht 2024
hinzugefügt 21.03.2026
CollPlant Biotechnologies Ltd. Abschreibung & Amortisation 2011-2026 | CLGN
Abschreibung & Amortisation Jährlich CollPlant Biotechnologies Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.04 M | 1.1 M | 1.08 M | 773 K | 660 K | 539 K | 342 K | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.1 M | 342 K | 790 K |
Abschreibung & Amortisation anderer Aktien in der Pharmaeinzelhändler
| Name | Abschreibung & Amortisation | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
31.7 M | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
3.65 M | - | - | $ 86.2 M | ||
|
AlloVir
ALVR
|
13 K | - | 4.14 % | $ 49.1 M | ||
|
Amgen
AMGN
|
5.17 B | $ 340.0 | -0.75 % | $ 183 B | ||
|
Amneal Pharmaceuticals
AMRX
|
57.3 M | $ 12.32 | -0.24 % | $ 3.86 B | ||
|
Applied Molecular Transport
AMTI
|
3.13 M | - | - | $ 10.1 M | ||
|
I-Mab
IMAB
|
23.9 M | - | - | $ 866 M | ||
|
Arcutis Biotherapeutics
ARQT
|
700 K | $ 23.27 | -1.63 % | $ 2.96 B | ||
|
Autolus Therapeutics plc
AUTL
|
8.3 M | $ 1.36 | -2.16 % | $ 362 M | ||
|
AVROBIO
AVRO
|
617 K | - | 1083.1 % | $ 745 M | ||
|
Ayala Pharmaceuticals
AYLA
|
162 K | - | - | $ 7.46 M | ||
|
BeiGene, Ltd.
BGNE
|
142 M | - | 0.49 % | $ 251 B | ||
|
CymaBay Therapeutics
CBAY
|
681 K | - | - | $ 3.45 B | ||
|
Advaxis
ADXS
|
369 K | - | -9.65 % | $ 45.9 M | ||
|
Aytu BioScience
AYTU
|
5.38 M | $ 2.57 | -3.38 % | $ 16.1 M | ||
|
Avid Bioservices
CDMO
|
11.1 M | - | - | $ 789 M | ||
|
Cidara Therapeutics
CDTX
|
154 K | - | - | $ 1.41 B | ||
|
Cellectar Biosciences
CLRB
|
214 K | $ 2.75 | 1.48 % | $ 7.17 M | ||
|
Aeterna Zentaris
AEZS
|
58 K | - | 5.93 % | $ 314 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
66 K | - | - | $ 231 M | ||
|
AgeX Therapeutics
AGE
|
100 K | - | -10.17 % | $ 12.2 K | ||
|
Concert Pharmaceuticals
CNCE
|
1.48 M | - | - | $ 401 M | ||
|
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.51 M | - | - | $ 26.5 M | ||
|
CTI BioPharma Corp.
CTIC
|
1.95 M | - | - | $ 1.2 B | ||
|
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | ||
|
Aptose Biosciences
APTO
|
22 K | - | -45.71 % | $ 1.2 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
5 K | - | -4.36 % | $ 27 M | ||
|
Cyclerion Therapeutics
CYCN
|
65 K | $ 3.48 | -16.14 % | $ 8.76 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
2.1 M | - | - | $ 2.18 B | ||
|
Akero Therapeutics
AKRO
|
18 K | - | - | $ 3.67 B | ||
|
Dynavax Technologies Corporation
DVAX
|
4.63 M | - | - | $ 2.02 B | ||
|
Coherus BioSciences
CHRS
|
1.3 M | $ 1.67 | - | $ 196 M | ||
|
Akari Therapeutics, Plc
AKTX
|
14 K | $ 3.8 | 7.34 % | $ 256 B | ||
|
Akouos
AKUS
|
2.49 M | - | 0.23 % | $ 488 M | ||
|
Allakos
ALLK
|
6.14 M | - | - | $ 28.6 M |